Patent · US Active

Treatment of obesity and pulmonary arterial hypertension

US9603852B2 · kind B2 · utility

0Cited by
3References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 17, 2014
Grant dateMar 28, 2017
Priority date—
Expiry dateJun 17, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are methods and compositions for treating pulmonary arterial hypertension and/or obesity using inhibitors of prostaglandin transporter (PGT) activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.